tirzepatide compound available Injectable | Compounded GLP-1/GIP weekly GLP Compounded Tirzepatide Weight Loss Program

Purpose-built for physicians Off-label semaglutide, tirzepatide lower HbA1c, weight in type 1 diabetes Key takeaways: Adults with type 1 diabetes had greater declines in HbA1c and body weight 1 year after being prescribed semaglutide or tirzepatide

Most patients need 4 vials (doses) per month

Blood work and lab monitoring during your taper Numbers do not lie

67 Tirzepatide initiation dose was 2.5 mg once weekly and increased by 2.5 mg every 4 weeks until reaching the target dose (a lower starting dose and a slower escalation regime compared to the phase 2 trial)

Clin Med (Lond) 2010;10:50912.ArticlePubMedPMC 4

These effects often reduce as the body adapts after the first week